Dosimetric Comparisons of Three-dimensional Conformal Radiotherapy,Intensity-Modulated Radiotherapy,and Helical Tomotherapy in Whole Abdominopelvic Radiotherapy for Gynecologic Malignancy

Abstract

Objectives

The goal of this study was to dosimetrically compare 3-dimensional radiotherapy (3DCRT), intensity-modulated radiotherapy (IMRT), and helical tomotherapy (TOMO) plans for whole abdominopelvic radiotherapy (WART) in patients with gynecologic cancer.

Methods

Ten patients were selected for WART planning. Doses were prescribed to planning target volumes (PTVs) as the followings: 30 Gy to PTV-whole abdominopelvis (PTV-WA), 40 Gy to PTV-para-aortic lymph node (PTV-PALN), 44 Gy to PTV-pelvis, and 50 Gy to gross target volume (GTV) in 20 fractions. Dose to whole liver, both kidneys, and spinal cord were constrained below each tissue tolerance, and bone marrow (BM)-sparing technique was adopted in IMRT and TOMO. Dosimetric parameters and treatment times were compared among plans.

Results

Calculated doses in TOMO came most closely to the prescribed dose for coverage of PTV-WA, PTV-PALN, PTV-pelvis, and GTV compared to 3DCRT, and IMRT. In normal organs, TOMO had significantly better dosimetric profiles compared to IMRT and 3DCRT. TOMO significantly reduced V_20Gy, and mean dose of whole liver, both kidneys, and spinal cord. The use of BM-sparing technique (BMS) did not impair coverage of target volume in IMRT and TOMO. While IMRT showed no differences of irradiated BM dose using BMS, TOMO with BMS reduced half V_20Gy of BM compared to TOMO without BMS.

Conclusions

TOMO showed dosimetric superiority in target coverage, sparing BM, and other normal organs compared to 3DCRT and IMRT. Clinical experiences will be needed for evaluation of feasibility of WART using TOMO in patients with gynecologic cancer.

Keywords

Helical tomotherapy Whole abdominopelvic radiotherapy Gynecologic cancer Bone marrow

References

Weiser

E. B.

Burke

T. W.

Heller

P. B.

Woodward

Hoskins

W. J.

Park

R. C.

Determinants of survival of patients with epithelial ovarian carcinoma following whole abdomen irradiation (WAR). Gynecol Oncol 30, 201–208 (1988).

Smith

J. P.

Rutledge

F. N.

Delclos

Postoperative treatment of early cancer of the ovary: A random trial between postoperative irradiation and chemotherapy. Natl Cancer Inst Monogr 42, 149–153 (1975).

Sell

Bertelsen

Andersen

J. E.

Stroyer

Panduro

Randomized study of whole-abdomen irradiation versus pelvic irradiation plus cyclophosphamide in treatment of early ovarian cancer. Gynecol Oncol 37, 367–373 (1990).

Klaassen

Shelley

Starreveld

Kirk

Boyes

Gerulath

Levitt

Fraser

Carmichael

Methot

Early stage ovarian cancer: A randomized clinical trial comparing whole abdominal radiotherapy, melphalan, and intraperitoneal chromic phosphate: a National Cancer Institute of Canada Clinical Trials Group report. J Clin Oncol 6, 1254–1263 (1988).

Hreshchyshyn

M. M.

Park

R. C.

Blessing

J. A.

Norris

H. J.

Levy

Lagasse

L. D.

Creasman

W. T.

The role of adjuvant therapy in Stage I ovarian cancer. Am J Obstet Gynecol 138, 139–145 (1980).

Goldberg

Peschel

R. E.

Postoperative abdominopelvic radiation therapy for ovarian cancer. Int J Radiat Oncol Biol Phys 14, 425–429 (1988).

Fuller

D. B.

Sause

W. T.

Plenk

H. P.

Menlove

R. L.

Analysis of postoperative radiation therapy in stage I through III epithelial ovarian carcinoma. J Clin Oncol 5, 897–905 (1987).

Dembo

A. J.

Radiotherapeutic management of ovarian cancer. Semin Oncol 11, 238–250 (1984).

Chiara

Conte

Franzone

Orsatti

Bruzzone

Rubagotti

Odicino

Rugiati

Carnino

Rosso

High-risk early-stage ovarian cancer. Randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy. Am J Clin Oncol 17, 72–76 (1994).

10.

Brixey

C. J.

Roeske

J. C.

Lujan

A. E.

Yamada

S. D.

Rotmensch

Mundt

A. J.

Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 54, 1388–1396 (2002).

11.

Beriwal

Gan

G. N.

Heron

D. E.

Selvaraj

R. N.

Kim

Lalonde

Kelley

J. L.

Edwards

R. P.

Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 68, 166–171 (2007).

12.

Salama

J. K.

Mundt

A. J.

Roeske

Mehta

Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies. Int J Radiat Oncol Biol Phys 65, 1170–1176 (2006).

13.

Hong

Alektiar

Chui

LoSasso

Hunt

Spirou

Yang

Amols

Ling

Fuks

Leibel

IMRT of large fields: Whole-abdomen irradiation. Int J Radiat Oncol Biol Phys 54, 278–289 (2002).

14.

Bush

R. S.

Allt

W. E.

Beale

F. A.

Bean

Pringle

J. F.

Sturgeon

Treatment of epithelial carcinoma of the ovary: Operation, irradiation, and chemotherapy. Am J Obstet Gynecol 127, 692–704 (1977).

15.

Dembo

A. J.

Bush

R. S.

Beale

F. A.

Bean

H. A.

Pringle

J. F.

Sturgeon

J. F.

The Princess Margaret Hospital study of ovarian cancer: Stages I, II, and asymptomatic III presentations. Cancer Treat Rep 63, 249–254 (1979).

16.

Schray

M. F.

Cox

R. S.

Martinez

Lower abdominal radiotherapy for stages I, II, and selected III epithelial ovarian cancer: 20 years experience. Gynecol Oncol 15, 78–87 (1983).

17.

Sorbe

Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: A randomized, controlled, clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatment. Int J Gynecol Cancer 13, 278–286 (2003).

18.

Cardenes

Randall

M. E.

Integrating radiation therapy in the curative management of ovarian cancer: Current issues and future directions. Semin Radiat Oncol 10, 61–70 (2000).

19.

Han

Liu

Schultheiss

T. E.

Pezner

R. D.

Chen

Y. J.

Wong

J. Y.

Dosimetric comparisons of helical tomotherapy treatment plans and step-and-shoot intensity-modulated radiosurgery treatment plans in intracranial stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 65, 608–616 (2006).

20.

Pezner

R. D.

Liu

Han

Chen

Y. J.

Schultheiss

T. E.

Wong

J. Y.

Dosimetric comparison of helical tomotherapy treatment and step-and-shoot intensity-modulated radiotherapy of retroperitoneal sarcoma. Radiother Oncol 81, 81–87 (2006).

21.

Lian

Mackenzie

Joseph

Pervez

Dundas

Urtasun

Pearcey

Assessment of extended-field radiotherapy for stage IIIC endometrial cancer using three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and helical tomotherapy. Int J Radiat Oncol Biol Phys 70, 935–943 (2008).

22.

Rochet

Sterzing

Jensen

Dinkel

Herfarth

Schubert

Eichbaum

Schneeweiss

Sohn

Debus

Harms

Helical tomotherapy as a new treatment technique for whole abdominal irradiation. Strahlenther Onkol 184, 145–149 (2008).

23.

Tierney

R. M.

Powell

M. A.

Mutch

D. G.

Gibb

R. K.

Rader

J. S.

Grigsby

P. W.

Acute toxicity of postoperative IMRT and chemotherapy for endometrial cancer. Radiat Med 25, 439–445 (2007).

24.

Mell

L. K.

Kochanski

J. D.

Roeske

J. C.

Haslam

J. J.

Mehta

Yamada

S. D.

Hurteau

J. A.

Collins

Y. C.

Lengyel

Mundt

A. J.

Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys 66, 1356–1365 (2006).

25.

Gerszten

Colonello

Heron

D. E.

Lalonde

R. J.

Fitian

I. D.

Comerci

J. T.

Selvaraj

R. N.

Varlotto

J. M.

Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix. Gynecol Oncol 102, 182–188 (2006).

26.

Fajardo

L. F.

Berthrong

Anderson

R. E.

Hematopoietic tissue. In: Fajardo L F, Berthrong, M, Anderson, R. E, editors. Radiation pathology. Vol 36; 2001. pp. 379–388.